MYGN · Company KPIs
Myriad Genetics (MYGN) KPIs
Total test volume, Cancer Care Continuum test volume, Prenatal Health test volume, Mental Health test volume. As reported in SEC filings, with the source line for each figure.
Total test volume
379,000 for the period ended Jun 30, 2026
The filings read for this page do not define this measure.
| Period ended | Figure | Filing text |
|---|---|---|
| Jun 30, 2026 | 379,000 | Total · 379 · 384 · (1)% · 764 · 769 · (1)%8-K filed 2026-07-30 |
| Mar 31, 2026 | 385,000 | Total · 385 · 385 · —%8-K filed 2026-05-05 |
| Dec 31, 2025 | 382,000 | Total · 382 · 374 · 2% · 1,537 · 1,520 · 1%8-K filed 2026-02-23 |
| Sep 30, 2025 | 386,000 | Total · 386 · 376 · 3% · 1,155 · 1,146 · 1%8-K filed 2025-11-03 |
| Jun 30, 2025 | 384,000 | Total · 379 · 384 · (1)% · 764 · 769 · (1)%8-K filed 2026-07-30 |
| Mar 31, 2025 | 385,000 | Total · 385 · 385 · —%8-K filed 2026-05-05 |
| Dec 31, 2024 | 374,000 | Total · 382 · 374 · 2% · 1,537 · 1,520 · 1%8-K filed 2026-02-23 |
| Sep 30, 2024 | 376,000 | Total · 386 · 376 · 3% · 1,155 · 1,146 · 1%8-K filed 2025-11-03 |
Cancer Care Continuum test volume
95,000 for the period ended Jun 30, 2026
The filings read for this page do not define this measure.
| Period ended | Figure | Filing text |
|---|---|---|
| Jun 30, 2026 | 95,000 | Cancer Care Continuum · 95 · 90 · 6% · 191 · 175 · 9%8-K filed 2026-07-30 |
| Mar 31, 2026 | 96,000 | Cancer Care Continuum · 96 · 85 · 13%8-K filed 2026-05-05 |
| Jun 30, 2025 | 90,000 | Cancer Care Continuum · 95 · 90 · 6% · 191 · 175 · 9%8-K filed 2026-07-30 |
| Mar 31, 2025 | 85,000 | Cancer Care Continuum · 96 · 85 · 13%8-K filed 2026-05-05 |
Prenatal Health test volume
144,000 for the period ended Jun 30, 2026
The filings read for this page do not define this measure.
| Period ended | Figure | Filing text |
|---|---|---|
| Jun 30, 2026 | 144,000 | Prenatal Health · 144 · 159 · (9)% · 297 · 332 · (11)%8-K filed 2026-07-30 |
| Mar 31, 2026 | 153,000 | Prenatal Health · 153 · 173 · (12)%8-K filed 2026-05-05 |
| Dec 31, 2025 | 150,000 | Prenatal · 150 · 160 · (6)% · 637 · 666 · (4)%8-K filed 2026-02-23 |
| Sep 30, 2025 | 155,000 | Prenatal · 155 · 162 · (4)% · 487 · 506 · (4)%8-K filed 2025-11-03 |
| Jun 30, 2025 | 159,000 | Prenatal Health · 144 · 159 · (9)% · 297 · 332 · (11)%8-K filed 2026-07-30 |
| Mar 31, 2025 | 173,000 | Prenatal Health · 153 · 173 · (12)%8-K filed 2026-05-05 |
| Dec 31, 2024 | 160,000 | Prenatal · 150 · 160 · (6)% · 637 · 666 · (4)%8-K filed 2026-02-23 |
| Sep 30, 2024 | 162,000 | Prenatal · 155 · 162 · (4)% · 487 · 506 · (4)%8-K filed 2025-11-03 |
Mental Health test volume
140,000 for the period ended Jun 30, 2026
The filings read for this page do not define this measure.
| Period ended | Figure | Filing text |
|---|---|---|
| Jun 30, 2026 | 140,000 | Mental Health · 140 · 135 · 4% · 276 · 262 · 5%8-K filed 2026-07-30 |
| Mar 31, 2026 | 136,000 | Mental Health · 136 · 127 · 7%8-K filed 2026-05-05 |
| Dec 31, 2025 | 138,000 | Mental Health · 138 · 127 · 9% · 537 · 507 · 6%8-K filed 2026-02-23 |
| Sep 30, 2025 | 137,000 | Pharmacogenomics · 137 · 127 · 8% · 399 · 380 · 5%8-K filed 2025-11-03 |
| Jun 30, 2025 | 135,000 | Mental Health · 140 · 135 · 4% · 276 · 262 · 5%8-K filed 2026-07-30 |
| Mar 31, 2025 | 127,000 | Mental Health · 136 · 127 · 7%8-K filed 2026-05-05 |
| Dec 31, 2024 | 127,000 | Mental Health · 138 · 127 · 9% · 537 · 507 · 6%8-K filed 2026-02-23 |
| Sep 30, 2024 | 127,000 | Pharmacogenomics · 137 · 127 · 8% · 399 · 380 · 5%8-K filed 2025-11-03 |
Reading notes
Figures are shown as first reported. If a later filing prints a different figure for the same period, both appear. A figure marked ≈ or shown in words is how the company itself states it, not an estimate of ours. Companies change definitions over time, so compare periods with the quoted definition in mind. Periods that failed our checks are left out, so gaps are expected.